Cargando…

Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine

Detalles Bibliográficos
Autores principales: Watts, Melissa M., Maurer, Laura E., Grammer, Leslie C., Saltoun, Carol A., Stevens, Whitney W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539818/
https://www.ncbi.nlm.nih.gov/pubmed/34699970
http://dx.doi.org/10.1016/j.anai.2021.10.021
_version_ 1784588838773981184
author Watts, Melissa M.
Maurer, Laura E.
Grammer, Leslie C.
Saltoun, Carol A.
Stevens, Whitney W.
author_facet Watts, Melissa M.
Maurer, Laura E.
Grammer, Leslie C.
Saltoun, Carol A.
Stevens, Whitney W.
author_sort Watts, Melissa M.
collection PubMed
description
format Online
Article
Text
id pubmed-8539818
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85398182021-10-25 Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine Watts, Melissa M. Maurer, Laura E. Grammer, Leslie C. Saltoun, Carol A. Stevens, Whitney W. Ann Allergy Asthma Immunol Letters American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022-02 2021-10-23 /pmc/articles/PMC8539818/ /pubmed/34699970 http://dx.doi.org/10.1016/j.anai.2021.10.021 Text en © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letters
Watts, Melissa M.
Maurer, Laura E.
Grammer, Leslie C.
Saltoun, Carol A.
Stevens, Whitney W.
Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine
title Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine
title_full Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine
title_fullStr Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine
title_full_unstemmed Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine
title_short Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine
title_sort delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger rna vaccine
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539818/
https://www.ncbi.nlm.nih.gov/pubmed/34699970
http://dx.doi.org/10.1016/j.anai.2021.10.021
work_keys_str_mv AT wattsmelissam delayedangioedemaafteradministrationofthesevereacuterespiratorysyndromecoronavirus2messengerrnavaccine
AT maurerlaurae delayedangioedemaafteradministrationofthesevereacuterespiratorysyndromecoronavirus2messengerrnavaccine
AT grammerlesliec delayedangioedemaafteradministrationofthesevereacuterespiratorysyndromecoronavirus2messengerrnavaccine
AT saltouncarola delayedangioedemaafteradministrationofthesevereacuterespiratorysyndromecoronavirus2messengerrnavaccine
AT stevenswhitneyw delayedangioedemaafteradministrationofthesevereacuterespiratorysyndromecoronavirus2messengerrnavaccine